To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
RSAD2 is abundant in atherosclerotic plaques and promotes interferon-induced CXCR3-chemokines in human smooth muscle cells
Örebro University, School of Medical Sciences.
Örebro University, School of Medical Sciences.ORCID iD: 0000-0002-2244-9816
Laboratory of Immunobiology, Division of Cardiovascular Medicine, Department of Medicine, Center for Bioelectronic Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Örebro University, School of Medical Sciences. Örebro University Hospital. Department of Cardiothoracic Surgery and Vascular Surgery.ORCID iD: 0000-0001-5585-1783
Show others and affiliations
2024 (English)In: Scientific Reports, E-ISSN 2045-2322, Vol. 14, no 1, article id 8196Article in journal (Refereed) Published
Abstract [en]

In atherosclerotic lesions, monocyte-derived macrophages are major source of interferon gamma (IFN-γ), a pleotropic cytokine known to regulate the expression of numerous genes, including the antiviral gene RSAD2. While RSAD2 was reported to be expressed in endothelial cells of human carotid lesions, its significance for the development of atherosclerosis remains utterly unknown. Here, we harnessed publicly available human carotid atherosclerotic data to explore RSAD2 in lesions and employed siRNA-mediated gene-knockdown to investigate its function in IFN-γ-stimulated human aortic smooth muscle cells (hAoSMCs). Silencing RSAD2 in IFN-γ-stimulated hAoSMCs resulted in reduced expression and secretion of key CXCR3-chemokines, CXCL9, CXCL10, and CXCL11. Conditioned medium from RSAD2-deficient hAoSMCs exhibited diminished monocyte attraction in vitro compared to conditioned medium from control cells. Furthermore, RSAD2 transcript was elevated in carotid lesions where it was expressed by several different cell types, including endothelial cells, macrophages and smooth muscle cells. Interestingly, RSAD2 displayed significant correlations with CXCL10 (r =  0.45, p = 0.010) and CXCL11 (r = 0.53, p = 0.002) in human carotid lesions. Combining our findings, we uncover a novel role for RSAD2 in hAoSMCs, which could potentially contribute to monocyte recruitment in the context of atherosclerosis.

Place, publisher, year, edition, pages
Nature Publishing Group, 2024. Vol. 14, no 1, article id 8196
National Category
Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:oru:diva-113037DOI: 10.1038/s41598-024-58592-9ISI: 001198838600052PubMedID: 38589444Scopus ID: 2-s2.0-85189798266OAI: oai:DiVA.org:oru-113037DiVA, id: diva2:1850004
Funder
Örebro UniversityKnowledge Foundation, 20180035Stiftelsen Gamla Tjänarinnor, 2020-01074; 2021-01198Stiftelsen Sigurd och Elsa Goljes minne, LA2020-0196Sjukvårdsregionala forskningsrådet Mellansverige, RFR-750481; RFR-940393Available from: 2024-04-09 Created: 2024-04-09 Last updated: 2025-02-10Bibliographically approved
In thesis
1. Impact of interferon-regulated genes on vascular cells and their implications for atherosclerosis
Open this publication in new window or tab >>Impact of interferon-regulated genes on vascular cells and their implications for atherosclerosis
2024 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Interferon gamma (IFN-γ) regulates the expression of numerous genes, many with known immunomodulatory, angiostatic, and antiviral functions. However, the functions of many of these genes in vascular cells and their implications for atherosclerosis remain to be fully understood.

In this thesis, we investigate the functions of IFN-γ-regulated genes in vascular cells to understand their implications for atherosclerosis. In Paper I, we demonstrate RSAD2, a gene strongly induced by IFN-γ, to regulate the expression of CXCR3 chemokines in vascular smooth muscle cells (VSMCs), which are crucial for monocyte migration in vitro. Both VSMCs and macrophages express RSAD2 within human carotid atherosclerotic lesions where RSAD2 also correlates with CXCL10 and CXCL11. In Paper II, we generated a mousemodel of atherosclerosis lacking one or both alleles for RSAD2 and report that RSAD2-deficient mice exhibit reduced body weight without significant differences in plaque size. In Paper III, we observed tumour necrosis factor alpha (TNF-α) to upregulate the expression of genes encoding laminin-332 (LN332). These genes are downregulated by IFN-γ (unpublished results included in this thesis). Endothelial cells, when cultured on LN332, acquire an atherogenic phenotype and the levels of two of the genes encoding LN332 are elevated in human carotid atherosclerotic lesions where they also correlate with TNF-α. In Paper IV we demonstrate IFN-γ to alter the expression of genes involved in glutamine metabolism in VSMCs. Among these, a significant downregulation is observed for the enzyme, glutaminase, which converts glutamine to glutamate, a precursor required for de novo glutathione synthesis, a molecule that counters oxidative damage. Notably, glutaminase expression is significantly reduced in human carotid atherosclerotic lesions. Furthermore, the expression pattern of genes associated with glutamine metabolism in IFN-γ-stimulated VSMCs closely resembles that observed in human carotid lesions. In summary, this thesis investigates the effects of IFN-γ-regulated genes on vascular cells and demonstrates that IFN-γ may exert both pro- and anti-atherogenic effects in vascular cells.

Place, publisher, year, edition, pages
Örebro: Örebro University, 2024. p. 74
Series
Örebro Studies in Medicine, ISSN 1652-4063 ; 304
Keywords
Endothelial cells, Glutamine, Glutaminase, Inflammation, Laminin, Monocytes, RSAD2, Smooth muscle cells, Viperin
National Category
Other Basic Medicine
Identifiers
urn:nbn:se:oru:diva-116067 (URN)9789175296029 (ISBN)9789175296036 (ISBN)
Public defence
2024-11-27, Örebro universitet, Campus USÖ, Tidefeltsalen, Södra Grev Rosengatan 32, Örebro, 13:00 (English)
Opponent
Supervisors
Available from: 2024-09-16 Created: 2024-09-16 Last updated: 2024-11-15Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Hayderi, AssimKumawat, Ashok KumarDreifaldt, MatsPetri, MarceloSirsjö, AllanLjungberg, Liza

Search in DiVA

By author/editor
Hayderi, AssimKumawat, Ashok KumarDreifaldt, MatsPetri, MarceloSirsjö, AllanLjungberg, Liza
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
Scientific Reports
Cardiology and Cardiovascular Disease

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 69 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf